Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies

Clinical Endocrinology

Volumn 76, Issue 5, 2012, Pages 617-624

  Baker, Peter R ^a   Nanduri, Priyaanka ^a   Gottlieb, Peter A ^a   Yu, Liping ^a   Klingensmith, Georgeanna J ^a   Eisenbarth, George S ^a   Barker, Jennifer M ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOTROPIN; HYDROCORTISONE; RENIN; STEROID 21 MONOOXYGENASE; TETRACOSACTIDE;

ADDISON DISEASE; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADDISON DISEASE; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; AUTOANTIBODIES; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENIN; STEROID 21-HYDROXYLASE; TIME FACTORS; YOUNG ADULT;

EID: 84859648355     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04276.x     Document Type: Article

References (30)

1. Erichsen, M.M., Lovas, K., Skinningsrud, B. et al. (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. Journal of Clinical Endocrinology and Metabolism, 94, 4882-4890.
2. Betterle, C., Dal Pra, C., Mantero, F. et al. (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews, 23, 327-364. (Pubitemid 34651950)
3. Falorni, A., Laureti, S., Nikoshkov, A. et al. (1997) 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clinical and Experimental Immunology, 107, 341-346. (Pubitemid 27049262)
4. Yu, L., Brewer, K.W., Gates, S. et al. (1999) DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. Journal of Clinical Endocrinology and Metabolism, 84, 328-335. (Pubitemid 29036722)
5. Giordano, R., Balbo, M., Picu, A. et al. (2006) Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? European Journal of Endocrinology, 155, 421-428. (Pubitemid 44463948)
6. Laureti, S., Aubourg, P., Calcinaro, F. et al. (1998) Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. Journal of Clinical Endocrinology and Metabolism, 89, 3163-3168. (Pubitemid 28500951)
7. Betterle, C., Volpato, M., Smith, B.R. et al. (1997) I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. Journal of Clinical Endocrinology and Metabolism, 82, 932-938. (Pubitemid 27106614)
8. Betterle, C., Volpato, M., Rees Smith, B. et al. (1997) II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. Journal of Clinical Endocrinology and Metabolism, 82, 939-942. (Pubitemid 27106615)
9. Coco, G., Dal Pra, C., Presotto, F. et al. (2006) Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. Journal of Clinical Endocrinology and Metabolism, 91, 1637-1645.
10. Betterle, C., Scalici, C., Presotto, F. et al. (1988) The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. Journal of Endocrinology, 117, 467-475.
11. Barker, J.M., Ide, A., Hostetler, C. et al. (2005) Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. Journal of Clinical Endocrinology and Metabolism, 90, 128-134. (Pubitemid 40116645)
12. Eisenbarth, G.S. & Gottlieb, P.A. (2004) Autoimmune polyendocrine syndromes. New England Journal of Medicine, 350, 2068-2079.
13. Falorni, A., Laureti, S., De Bellis, A. et al. (2004) Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 89, 1598-1604. (Pubitemid 38507908)
14. Badenhoop, K., Walfish, P.G., Rau, H. et al. (1995) Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. Journal of Clinical Endocrinology and Metabolism, 80, 2112-2117.
15. Alper, C.A., Larsen, C.E., Dubey, D.P. et al. (2006) The haplotype structure of the human major histocompatibility complex. Human Immunology, 67, 73-84. (Pubitemid 43673910)
16. Gambelunghe, G., Falorni, A., Ghaderi, M. et al. (2006) Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. Journal of Clinical Endocrinology and Metabolism, 84, 3701-3707.
17. Gombos, Z., Hermann, R., Kiviniemi, M. et al. (2007) Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. European Journal of Endocrinology, 157, 757-761.
18. Weetman, A.P., Zhang, L., Tandon, N. et al. (1999) HLA associations with autoimmune Addison's disease. Tissue Antigens, 38, 31-33.
19. Neufeld, M., Maclaren, N.K. & Blizzard, R.M. (1981) Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore), 60, 355-362. (Pubitemid 12247574)
20. Bilbao, J.R., Martin-Pagola, A., Perez de Nanclares, G. et al. (2003) HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Annals of the New York Academy of Sciences, 1005, 314-318. (Pubitemid 38507776)
21. Eisenbarth, G.S., Wilson, P., Ward, F. et al. (1978) HLA type and occurrence of disease in familial polyglandular failure. New England Journal of Medicine, 298, 92-94. (Pubitemid 8260219)
22. Baker, P.R., Baschal, E.E., Fain, P.R. et al. (2010) Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. Journal of Clinical Endocrinology and Metabolism, 95, E263-E270.
23. Triolo, T.M., Baschal, E.E., Armstrong, T.K. et al. (2010) Homozygosity of the polymorphism MICA5Æ1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism, 94, 4517-4523.
24. Baker, P.R., Baschal, E.E., Fain, P.R. et al. (2011) Dominant suppression of Addison's disease associated with HLA-B15. Journal of Clinical Endocrinology and Metabolism, 96, 2154-2162.
25. Laureti, S., De Bellis, A., Muccitelli, V.I. et al. (1998) Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. Journal of Clinical Endocrinology and Metabolism, 83, 3507-3511. (Pubitemid 28500880)
26. Meager, A., Visvalingam, K., Peterson, P. et al. (2006) Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Medicine, 3, e289.
27. Horrocks, P.M. & London, D.R. (1982) Diagnostic value of 9 am plasma adrenocorticotrophic hormone concentrations in Cushing's disease. British Medical Journal (Clinical Research Edition), 285, 1302-1303. (Pubitemid 12036876)
28. Martinez-Aguayo, A., Aglony, M., Campino, C. et al. (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension, 56, 391-396.
29. May, M.E. & Carey, R.M. (1985) Rapid adrenocorticotropic hormone test in practice. Retrospective review. American Journal of Medicine, 79, 679-684. (Pubitemid 16170124)
30. Speckart, P.F., Nicoloff, J.T. & Bethune, J.E. (1971) Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH). Archives of Internal Medicine, 128, 761-763.